The Quick Answer
GLP-1 side effects are mostly gastrointestinal: nausea, constipation, diarrhea, and occasional vomiting. In the SURMOUNT-1 trial of tirzepatide, nausea was reported by roughly 25 to 33 percent of participants depending on dose, and most events were mild to moderate and clustered during the dose-escalation period.1 In the STEP-1 trial of semaglutide, about 74 percent of participants reported a GI symptom at some point, with nausea the most common at 44 percent, again mostly mild to moderate and concentrated during titration.2 The practical fixes are eating smaller and slower, easing up on fat and fried food, hydrating, and titrating gradually under medical supervision. At Defiant in Lisle, we titrate bi-weekly with weekly nurse check-ins, which gives us room to slow the ramp the moment side effects get loud.
Most GLP-1 side effects are mild, digestive, and temporary. Nausea, constipation, and the occasional bout of diarrhea are the usual suspects, and they tend to show up while your dose is climbing, then settle as your body adjusts. The single biggest lever you have over side effects is how slowly you titrate.
This post covers which side effects are common, why they happen, how long they last, and the practical steps that may help you stay comfortable. It also explains why a slow, supervised dose ramp matters more than the number on the pen.
Why GLP-1s Cause Side Effects
GLP-1 medications work partly by slowing how fast your stomach empties. That slower gastric emptying is intentional. It is part of why you feel full sooner and stay full longer. The same mechanism is also why the side effects are mostly digestive. Food sits longer, so eating too much or too fast can tip you into nausea or fullness that borders on uncomfortable.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Semaglutide is a GLP-1 receptor agonist. Both are given as a once-weekly subcutaneous injection, and both affect appetite signaling in the gut and brain. When people describe the medication "quieting the food noise," they are describing the same appetite pathway that, dialed too fast, produces nausea.
The takeaway: side effects usually mean your dose climbed faster than your gut wanted. That is fixable.
The Most Common GLP-1 Side Effects
The side effects are overwhelmingly gastrointestinal, and the trial data is consistent on which ones show up most.
| Side effect | Tirzepatide (SURMOUNT-1)1 | Semaglutide (STEP-1)2 |
|---|---|---|
| Nausea | ~25 to 33% | ~44% |
| Diarrhea | ~19 to 23% | ~32% |
| Constipation | ~12 to 17% | ~23% |
| Vomiting | ~8 to 12% | ~25% |
A few things to read from this table. First, these are the percentages of people who reported the symptom at any point across the trial, not the percentage feeling sick at any given moment. Second, most events were rated mild to moderate.12 Third, the numbers rise with dose, which is exactly why the starting dose is low and the climb is gradual.
Beyond the GI symptoms, some people notice fatigue, headache, or a temporary drop in appetite for foods they used to love. Injection-site reactions are usually minor. Heartburn and burping come up anecdotally and often trace back to eating too much, too fast.
How Long Side Effects Last
For most people, side effects are worst in the first days after a dose increase and ease within a week or two as the body adjusts. The reason they cluster early is structural: the GI symptoms concentrate during the titration period rather than at a steady maintenance dose.2 Once you settle at a dose your body tolerates, symptoms usually quiet down.
That is the logic behind the standard four-week dose steps. A low starting dose with gradual escalation is designed to reduce the gastrointestinal load, which is why the FDA-labeled titration schedules ramp slowly rather than jumping to an effective dose.3
If nausea is still rough weeks into a stable dose, that is worth a conversation with your provider. It often means the last step up was too big or too soon.
How to Manage Nausea and GI Symptoms
Most GLP-1 side effects respond to behavior changes. These are practical habits many patients find helpful. None replace your provider's guidance, and you should always run new strategies past the person managing your protocol.
For nausea:
- Eat smaller portions and stop at the first sign of fullness. Slower gastric emptying means the "I'm full" signal arrives late, so pre-empt it.
- Slow down. Put the fork down between bites. Speed is a common nausea trigger.
- Go lighter on fatty, fried, and very rich foods, which sit heaviest in a slow-emptying stomach.
- Stay hydrated. Sip water through the day rather than chugging with meals.
- Bland, lower-fat foods on dose-increase days can make the transition easier.
For constipation:
- Fiber and fluids. Vegetables, fruit, whole grains, and enough water do most of the work.
- Move your body. A daily walk supports normal gut motility.
- Ask your provider about a fiber supplement or a gentle stool softener if it persists.
For diarrhea:
- Pull back on greasy and very rich foods.
- Keep fluids up to stay ahead of dehydration.
- Flag it to your provider if it lasts more than a day or two.
The thread running through all of this: your medication is slowing your digestion on purpose, so eating in a way that respects a slower gut is the core skill. Protein still matters, especially when you are losing weight, because adequate protein and resistance training may support preserving lean muscle during weight loss. That is one reason muscle-preservation coaching pairs well with a GLP-1 protocol.
Why Slow Titration Is the Real Fix
The most effective side-effect strategy is the speed of your dose ramp.
Gastrointestinal side effects cluster during dose escalation and ease at a stable dose.2 So the slower and more responsive your titration, the more comfortable the ride. The trade-off most telehealth programs make is a rigid monthly step-up: same schedule for everyone, regardless of how your gut is handling it. If a dose increase lands hard, you may be stuck waiting weeks for the next check-in.
Defiant titrates bi-weekly rather than monthly. Two-week intervals give a provider more frequent decision points, which means we can hold a dose, slow the climb, or adjust sooner when side effects flare, instead of pushing ahead on a fixed calendar. Bi-weekly titration is the differentiator. It exists precisely so the dose can track how your body is actually responding.
When to Call Your Provider
Most side effects are mild and ease as your body adjusts, but a small number are serious and uncommon. This post is general education, not medical advice. If any side effect feels severe, persistent, or unusual, contact your provider promptly, and if you think you are having an emergency, call 911 or go to the nearest emergency room.
Because the warning signs that matter most depend on your health history, your prescriber will review what to watch for during your intake and ongoing check-ins. That is one reason starting under medical supervision matters.
How Defiant Handles Side Effects in Lisle
Every medical weight loss protocol at Defiant starts with a provider consult, a lab review, and a Styku 3D body composition scan as your baseline. From there, the medication is titrated bi-weekly with weekly nurse check-ins, so there is a real person to message when nausea shows up on a Tuesday night.
That cadence is the difference. Side effects are easiest to manage when someone can adjust your protocol quickly, rather than leaving you to white-knuckle a dose for a month. We offer both tirzepatide and semaglutide protocols, with dosing built around your labs, your tolerance, and your goals.
We also track more than the scale. Body composition scanning shows whether you are losing fat while holding lean mass, and GLP-1 muscle-preservation training is available as an add-on to protect strength during weight loss.
Defiant is at 5100 Lincoln Ave in Lisle, serving Naperville, Downers Grove, Wheaton, Oak Brook, and Chicago's western suburbs.
- GLP-1 side effects are mostly gastrointestinal: nausea, constipation, diarrhea, and occasional vomiting. They happen because the medication slows gastric emptying on purpose.
- Most events are mild to moderate and cluster during dose escalation, then ease as you settle at a stable dose.
- In SURMOUNT-1, nausea affected roughly 25 to 33 percent of tirzepatide participants; in STEP-1, about 44 percent of semaglutide participants reported nausea, most of it mild to moderate.
- Practical management means smaller and slower meals, lighter fat intake, hydration, fiber for constipation, and adequate protein to support lean muscle.
- The biggest lever is titration speed. A slower, more responsive dose ramp reduces side effects, which is why Defiant titrates bi-weekly with weekly nurse check-ins.
- A few side effects are serious but uncommon. If anything feels severe, persistent, or unusual, contact your provider, and your prescriber will review your health history before starting.
Common Questions
Slower Ramp. Steadier Start.
Bi-weekly titration and weekly nurse check-ins mean your dose tracks how your body actually responds week to week. Book a consultation and start a GLP-1 protocol built around your biology.
Keep Reading
Last updated June 20, 2026.
References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022. NEJM (SURMOUNT-1)
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). New England Journal of Medicine. 2021. NEJM (STEP-1)
- U.S. Food and Drug Administration. Wegovy (semaglutide) injection, prescribing information. 2025. FDA label (PDF)